Related Experiment Video

Updated: Apr 7, 2026

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
11:17

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Published on: August 30, 2018

13.6K

New Horizons for Pediatric Antibiotic Stewardship

Jennifer L Goldman1, Jason G Newland2

  • 1Division of Pediatric Infectious Diseases, Department of Pediatrics, Children's Mercy Hospitals & Clinics, University of Missouri-Kansas City School of Medicine, 2401 Gillham Road, Kansas City, MO 64108, USA; Division of Clinical Pharmacology, Department of Pediatrics, Children's Mercy Hospitals & Clinics, University of Missouri-Kansas City School of Medicine, 2401 Gillham Road, Kansas City, MO 64108, USA.

Infectious Disease Clinics of North America
|July 9, 2015
PubMed

Insights

Antimicrobial stewardship programs (ASPs) effectively reduce inappropriate antimicrobial use, a key factor in combating antibiotic resistance. Pediatric ASPs are expanding, demonstrating value in optimizing antibiotic use in children through collaborative efforts.

Area of Science:

  • Infectious Diseases
  • Public Health
  • Pediatrics

Background:

  • Antibiotic resistance is a significant global health concern.
  • Overuse of antimicrobials exacerbates the problem of antibiotic resistance.
  • Antimicrobial stewardship programs (ASPs) are crucial for controlling antimicrobial use.

Purpose of the Study:

  • To highlight the effectiveness of pediatric antimicrobial stewardship programs (ASPs).
  • To emphasize the growing recognition and expansion of ASPs in healthcare.
  • To underscore the importance of collaborative efforts in optimizing antimicrobial use in children.

Main Methods:

  • Review of current literature on antimicrobial stewardship programs.
  • Analysis of the impact of pediatric ASPs on antimicrobial utilization.
  • Examination of collaborative initiatives among pediatric ASPs.

Main Results:

  • Pediatric ASPs have proven effective in optimizing antimicrobial use in children.
  • The value of ASPs is increasingly recognized across various healthcare settings.
  • Collaborative efforts are enhancing best practices for minimizing unnecessary antimicrobial prescriptions.

Conclusions:

  • Antimicrobial stewardship programs are vital in combating antibiotic resistance.
  • The expansion and collaboration of pediatric ASPs are essential for improving antimicrobial use in pediatric populations.
  • Continued development and implementation of ASPs are necessary to address the threat of antimicrobial resistance.

Keywords:
Antimicrobial resistanceAntimicrobial stewardshipPediatrics

More Related Videos

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method12:03

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method

Published on: April 18, 2019

28.1K
A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii09:17

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

15.4K

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
380
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
776
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
43
Antibiotic Selection00:57

Antibiotic Selection

Overview
62.2K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
346
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
2.0K